Growth Metrics

Aehr Test Systems (AEHR) Gains from Sales and Divestitures (2016 - 2026)

Aehr Test Systems' Gains from Sales and Divestitures history spans 11 years, with the latest figure at $64000.0 for Q1 2026.

  • For Q1 2026, Gains from Sales and Divestitures fell 7.25% year-over-year to $64000.0; the TTM value through Feb 2026 reached $64000.0, down 7.25%, while the annual FY2025 figure was $194000.0, 14.12% up from the prior year.
  • Gains from Sales and Divestitures reached $64000.0 in Q1 2026 per AEHR's latest filing, down from $76000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $240000.0 in Q2 2023 to a low of $28000.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 5 years is $99529.4, with a median of $76000.0 recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 436742.11% in 2022, then tumbled 85.52% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $60000.0 in 2022, then crashed by 53.33% to $28000.0 in 2023, then surged by 67.86% to $47000.0 in 2024, then soared by 61.7% to $76000.0 in 2025, then decreased by 15.79% to $64000.0 in 2026.
  • Per Business Quant, the three most recent readings for AEHR's Gains from Sales and Divestitures are $64000.0 (Q1 2026), $76000.0 (Q4 2025), and $61000.0 (Q3 2025).